ArticleOncology and therapy2025

Pembrolizumab-Induced High Inflammatory Panmyelitis: Contribution of Neurochemical Markers Predicting Severity of Central Nervous Affection.

Beate Hagenkötter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.